GR3003254T3 - Method for treating iron overload - Google Patents

Method for treating iron overload

Info

Publication number
GR3003254T3
GR3003254T3 GR91401882T GR910401882T GR3003254T3 GR 3003254 T3 GR3003254 T3 GR 3003254T3 GR 91401882 T GR91401882 T GR 91401882T GR 910401882 T GR910401882 T GR 910401882T GR 3003254 T3 GR3003254 T3 GR 3003254T3
Authority
GR
Greece
Prior art keywords
iron overload
iron
mammal
red blood
treating iron
Prior art date
Application number
GR91401882T
Other languages
English (en)
Inventor
John William Adamson
Michael Richard Downing
Joseph Wetherill Eschbach
Joan Christine Egrie
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Publication of GR3003254T3 publication Critical patent/GR3003254T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Manufacture Of Iron (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Hydrogen, Water And Hydrids (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
GR91401882T 1986-11-21 1991-12-02 Method for treating iron overload GR3003254T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,495 US5013718A (en) 1986-11-21 1986-11-21 Method for treating iron overload using EPO

Publications (1)

Publication Number Publication Date
GR3003254T3 true GR3003254T3 (en) 1993-02-17

Family

ID=25464076

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401882T GR3003254T3 (en) 1986-11-21 1991-12-02 Method for treating iron overload

Country Status (16)

Country Link
US (1) US5013718A (el)
EP (1) EP0269394B1 (el)
JP (1) JPH0692316B2 (el)
KR (1) KR950009100B1 (el)
AT (1) ATE68352T1 (el)
AU (1) AU602028B2 (el)
CA (1) CA1322165C (el)
DE (1) DE3773852D1 (el)
DK (1) DK167650B1 (el)
ES (1) ES2039252T3 (el)
GR (1) GR3003254T3 (el)
IE (1) IE60865B1 (el)
IL (1) IL84275A (el)
NZ (1) NZ222432A (el)
PT (1) PT86187B (el)
WO (1) WO1988003808A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
WO1996014081A1 (en) * 1994-11-03 1996-05-17 Boehringer Mannheim Gmbh Use of erythropoietin in the treatment of rheumatoid arthritis
CA2216443A1 (en) 1995-03-31 1996-10-03 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
TW586933B (en) 1996-06-20 2004-05-11 Chugai Pharmaceutical Co Ltd Compositions for treating liver-complaints using EPO
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
EP0965349A1 (de) * 1998-06-18 1999-12-22 Roche Diagnostics GmbH Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
AR019025A1 (es) 1998-04-09 2001-12-26 Roche Diagnostics Gmbh Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
DE19857609A1 (de) * 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
AU3269101A (en) * 1999-11-12 2001-06-06 James C. Barton Diagnostic test for hemochromatosis
US7160855B2 (en) * 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
KR101248252B1 (ko) 2006-11-28 2013-03-27 한올바이오파마주식회사 변형된 에리스로포이에틴 폴리펩티드와 이의 치료용 용도
WO2012174157A1 (en) * 2011-06-13 2012-12-20 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
US10694962B2 (en) 2011-06-13 2020-06-30 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
FR3037592B1 (fr) 2015-06-18 2017-06-09 Michelin & Cie Pneumatique pourvu d'une bande de roulement comprenant un elastomere dienique et un systeme d'elastomeres thermoplastiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4667016A (en) * 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification

Also Published As

Publication number Publication date
IL84275A (en) 1993-04-04
IE873113L (en) 1988-05-21
AU8179487A (en) 1988-06-16
KR890700032A (ko) 1989-03-02
DE3773852D1 (de) 1991-11-21
EP0269394A3 (en) 1988-09-14
EP0269394A2 (en) 1988-06-01
WO1988003808A1 (en) 1988-06-02
US5013718A (en) 1991-05-07
DK167650B1 (da) 1993-12-06
PT86187A (en) 1987-12-01
PT86187B (pt) 1990-11-07
IE60865B1 (en) 1994-08-24
CA1322165C (en) 1993-09-14
ATE68352T1 (de) 1991-11-15
DK407488D0 (da) 1988-07-21
DK407488A (da) 1988-07-21
AU602028B2 (en) 1990-09-27
ES2039252T3 (es) 1993-09-16
JPS63159322A (ja) 1988-07-02
JPH0692316B2 (ja) 1994-11-16
KR950009100B1 (ko) 1995-08-14
NZ222432A (en) 1990-07-26
EP0269394B1 (en) 1991-10-16

Similar Documents

Publication Publication Date Title
EP0269394A3 (en) Method for treating iron overload
EP0177137A3 (en) White blood cell differentiation composition and method
GB2082385B (en) Process for manufacture of high power mosfet with laterally distributed high carrier density beneath the gate oxide
MY101209A (en) Production of m-csf.
AU6760987A (en) Method of treating alzheimer's disease
KR880701736A (ko) Il-6의 제조방법 및 용도
AU587689B2 (en) Zinc-nickel alloy electrolyte and process
GR3004071T3 (el)
ZA883115B (en) Treatment of diabetes
EP0168325A3 (en) Ion implantation to increase emitter energy gap in bipolar transistors
PH15186A (en) Method of regulating the production and metabolism of prostaglandin in a mammal
ES8706110A1 (es) Un procedimiento para la preparacion de derivados de alfa-aminoalquil-alfa-alquilfenilacetonitrilo.
EP0192807A3 (en) Process for manufacturing active briquettes rich in carbon
AU6225386A (en) Method of preparing pulp with stabilizers and peroxide prior to mechanical refining
JPS55126510A (en) Method of concentrating and refining sulfuric acid
CS476288A2 (en) Method of 3-(3-pyridyle)-1h,3h-pyrrolo (1,2-0)-thiazole-7-carboxylic dextrorotary acid production
ZA824576B (en) Process for preventing losses of vanadium in oxidative hydrogen sulphide scrubbings
HUT42671A (en) Method for producing novel tetraploide chamomille rich in bisabold of improved feature
ES481724A1 (es) Una conduccion de barras coladas destinada a una instalacionde colada continua.
ES2013123A6 (es) Un procedimiento para la preparacion de oxidos de 1,2,4-benzotriazina.
EP0030345A3 (de) Verfahren zum Verhütten antimonhaltiger bleireicher Vorstoffe
EP0164087A3 (en) Process for reducing the sulphuric acid and impurity content in wet-process phosphoric acid
EP0150737A3 (en) Process for treating nuclear fuel scrap
JPS6464360A (en) Gto thyristor
ES428172A1 (es) Un procedimiento para preparar acido 5-pivaloiloxi-5-(1-fe-niletil)-barbiturico.